or Try an Advanced Search...

    Treatment Of Cancer Stocks List

    Symbol Grade Name % Change
    ALPN A Alpine Immune Sciences, Inc. 0.02
    MACK B Merrimack Pharmaceuticals, Inc. -0.13
    RNA B Avidity Biosciences, Inc. 0.23
    GTHX C G1 Therapeutics, Inc. -3.14
    CATX C Perspective Therapeutics, Inc. -0.57
    STTK C Shattuck Labs, Inc. -0.67
    TGTX C TG Therapeutics, Inc. 4.21
    CNTX C Context Therapeutics Inc. -10.16
    ELTX C Elicio Therapeutics, Inc. 2.55
    PRPO C Precipio, Inc. 4.06
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Disease Biology Breast Cancer Medicine Clinical Development Clinical Medicine Her2 Her2/Neu Immunotherapies Life Sciences Lymphoma Monoclonal Antibody Personalized Medicine Pharmaceutical Products Solid Tumors Treatment Of Breast Cancer Advanced Solid Tumors

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cancer stocks.

    Symbol Grade Name Weight
    MOON F Direxion Moonshot Innovators ETF 7.47
    PTH D Invesco DWA Healthcare Momentum ETF 6.84
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 6.11
    SBIO D ALPS Medical Breakthroughs ETF 4.09
    GNOM D Global X Genomics & Biotechnology ETF 3.56
    View all Treatment Of Cancer ETFs...
    Compare ETFs
    Compare MOON to BBC Compare MOON to GNOM Compare SBIO to GNOM

        Treatment Of Cancer Stocks Recent News

        Date Stock Title
        May 10 MACK Merrimack Pharmaceuticals stockholders approve plan of dissolution
        May 10 MACK Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
        May 10 ALPN Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
        May 10 ALPN Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires
        May 9 ALPN Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.12, revenue of $7.03M beats by $3.51M
        May 9 RNA Avidity Biosciences GAAP EPS of -$0.79 beats by $0.07, revenue of $3.54M beats by $0.97M
        May 9 RNA Avidity Biosciences files automatic mixed shelf
        May 9 RNA Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
        May 9 ALPN Alpine Immune Sciences Reports First Quarter 2024 Financial Results
        May 9 MACK Merrimack Pharmaceuticals intends to declare $15.10 dividend
        May 9 GTHX G1 Therapeutics jumps amid takeover speculation (update)
        May 9 MACK Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
        May 8 RNA Avidity gets FDA breakthrough therapy status for DM1 drug
        May 8 RNA Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) for Treatment of Myotonic Dystrophy Type 1
        May 7 STTK What Makes Shattuck Labs (STTK) a New Buy Stock
        May 7 ALPN Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
        May 7 STTK Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
        May 7 ALPN Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
        May 7 ALPN Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
        May 7 ALPN Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
        Related Stock Lists: Cancer Biopharmaceutical Biotechnology Disease Biology Breast Cancer Medicine Clinical Development Clinical Medicine Her2 Her2/Neu Immunotherapies Life Sciences Lymphoma Monoclonal Antibody Personalized Medicine Pharmaceutical Products Solid Tumors Treatment Of Breast Cancer Advanced Solid Tumors
        Treatment Of Cancer

        Treatment of cancer depends on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and/or hormone therapy. In some cases, a combination of treatments may be used.

        Browse All Tags